Processing of Antigenic Peptides by Aminopeptidases

Processing of Antigenic Peptides by Aminopeptidases

June 2004 Biol. Pharm. Bull. 27(6) 777—780 (2004) 777 Current Topics Aminopeptidases in Health and Disease Processing of Antigenic Peptides by Aminopeptidases Akira HATTORI* and Masafumi TSUJIMOTO Laboratory of Cellular Biochemistry, RIKEN; 2–1 Hirosawa, Wako, Saitama 351–0198, Japan. Received January 7, 2004 Antigenic peptides presented to major histocompatibility complex (MHC) class I molecules are generated in the cytosol during degradation of cellular proteins by the ubiquitin-proteasome proteolytic pathway. Proteasome can generate N-extended precursors as well as final epitopes, and then the precursors are processed to mature epitopes by aminopeptidases. Both cytosolic peptidases (i.e. puromycin-sensitive aminopeptidase, bleomycin hy- drolase and interferon-g-inducible leucine aminopeptidase) and recently identified metallo-aminopeptidase lo- cated in the endoplasmic reticulum (i.e. adipocyte-derived leucine aminopeptidase/endoplasmic reticulum aminopeptidase 1 and leukocyte-derived arginine aminopeptidase) can generate final epitopes from precursor peptides. Some of these aminopeptidases are also considered to destroy certain antigenic peptides to limit the antigen presentation. Taken together, it is getting evident that aminopeptidases located in the cytosol and the lumen of endoplasmic reticulum play important roles in the generation of antigenic peptides presented to MHC class I molecules. Key words aminopeptidase; antigen processing; major histocompatibility complex (MHC) class I; antigen presentation; protea- some; protein degradation The adaptive immune system has evoked to protect organ- alanyl-phenylalanyl-7-amino-4-methylcoumarin (AAF- ism against pathogens. Central to maintaining immunity is AMC) which is a substrate for tricon protease, a large pro- cell-surface presentation of antigenic peptides to specific re- tease complex in Thermoplasma, was increased, suggesting ceptors on CD8ϩ cytotoxic T lymphocytes by class I major that AAF-AMC cleaving activity in adapted cells could com- histocompatibility complex (MHC) molecules on infected pensate for the loss of proteasome function in antigen pre- cells. This cell-mediated recognition process results in the sentation. One of the responsible enzymes for AAF-AMC elimination of infected cells and is critically important to hydrolytic activity was co-purified with 26S proteasomes and maintain immunity against virus and tumors. identified as tripeptidyl peptidase (TPP) II.6) TPP II pos- By recent numerous studies, the comprehension how sesses predominantly trypsin-like endoproteolytic activity as MHC class I ligands are generated has increased. Especially, well as aminopeptidase activity that removes tripeptides se- during the last years, it has been clarified that several quentially from free N-termini of peptides.6,7) TPP II and aminopeptidases can contribute to the processing of anti- proteasome cleaved 41-mer polypeptide products derived genic peptides presented to MHC class I molecules. In this from ovalbumin differently from each other. Furthermore, it review, the current knowledge about the role of aminopepti- was suggested that in human dendritic cells TPP II can gen- dases in the antigen generation is summarized. erate immunodominant human immunodeficiency virus (HIV) epitope, HIV-Nef (73—82), independently from pro- CYTOSOLIC PROCESSING OF ANTIGENIC PEPTIDES teosome. These observations suggest that TPP II can degrade certain antigen proteins to peptide fragments distinct from It is well established that cytosolic proteolysis is the major that generated by proteasome, increasing the complexity of source of MHC class I bound ligands.1) Most of these 8—11 the MHC class I peptide repertoire. residue peptides are derived from peptides generated in the cytosol or nucleus during protein degradation by the ubiqui- TRIMMING AND DESTROY OF ANTIGENIC PEPTIDES tin-proteasome pathway.2—4) Accordingly, inhibitors of pro- IN THE CYTOSOL teasome block MHC class I antigen presentation.2) Most of peptides degraded by proteasome are hydrolyzed quickly to Ligands for the MHC class I molecules are composed of amino acids by cytosolic peptidases, while some peptides es- peptides of 8—11 a.a. in length. Proteasome degrades the cape from further degradation, transported into the endoplas- bulk of intracellular proteins and generates peptides ranging mic reticulum (ER) and presented on MHC class I mole- from 2 to 25 a.a. in length.8) Whereas some antigenic pep- cules. tides are directly produced by the proteasome in their final While proteasome plays the major role in the generation of forms, others are produced as precursor peptides. In regard to antigen peptides, involvement of other proteases in this precursors of epitopes, Craiu et al. examined which termini process has been also demonstrated. Glas et al. exposed of precursor of antigenic peptide might be generated by pro- membrane permeable proteasome inhibitor, NLVS, to EL-4 teasome.9) It was revealed that proteasome inhibitor blocked lymphoma and cloned resistant cell line which termed the presentation of a chicken ovalbumin-derived antigenic adapted cells.5) Although the activity of proteasome was epitope, SIINFEKL, with a C-terminal extension, but not markedly decreased in the cells, hydrolytic activity to alanyl- with an N-terminal extension. These results suggest that ∗ To whom correspondence should be addressed. e-mail: [email protected] © 2004 Pharmaceutical Society of Japan 778 Vol. 27, No. 6 while proteasome mediates proper C-terminal cleavage for drolyzed into amino acids rapidly. Antigenic peptides and the generation of several immunodominant class I-presented their precursors are also thought to be degraded to amino peptides, precursors of antigenic peptides with N-terminal acids efficiently. Saric and colleagues searched the metallo- extensions require further processing to final epitopes by peptidases which might degrade antigenic peptides and some aminopeptidases after the proteasome action.9,10) found that cytosolic peptidases such as PSA and thimet In efforts to identify trimming aminopeptidases, leucine oligopeptidase are involved in antigen degradation both in aminopeptidase (LAP) was first identified by Beninga et vitro and in vivo.21,22) In addition, some chaperones such as al.11) They tested the effects of interferon (IFN)-g, which en- Hsp 70, Hsp 90 and group II chaperonin TRiC can protect hances several important steps of antigen presentation, on the proteasome products from further degradation.23,24) It is con- degradation of ovalbumin-derived antigenic peptide precur- sidered that the regulation of antigenic peptide degradation sor QLESIINFEKL in the cytosol. IFN-g enhanced degrada- by these proteins is an important factor to determine the effi- tion of the precursor peptide and generation of final epitope ciency of antigen presentation. SIINFEKL in HeLa and U937 cells. They also examined the hydrolytic activity toward various amino acid-AMC in solu- PROCESSING OF ANTIGENIC PRECURSORS IN THE ble fraction from HeLa and U937 cells to investigate the ER LUMEN aminopeptidases involved in the trimming of antigenic pep- tide precursors. In IFN-g-stimulated cells, hydrolytic activity Antigenic peptides generated in the cytosol are transported to several substrates such as Leu-, Lys-, Met-, Cys- and Phe- into the ER lumen by transporters associated with antigen AMC were enhanced, indicating the presence of IFN-g- processing (TAP) heterodimmer, TAP1 and TAP2, and inducible aminopeptidases in the cytosol. Since the substrate loaded onto newly synthesized MHC class I molecules.25) It specificity of IFN-g-inducible aminopeptidase was similar to was shown that some mature epitopes presented efficiently to that of LAP purified from porcine kidney, LAP was consid- MHC class I molecules often show very low affinities to ered as an IFN-g-inducible aminopeptidase involved in the TAPs. On the other hand, N-extended precursors of these epi- antigen processing.12) In addition, LAP can generate a final topes reveal high affinities to TAPs and presented efficiently antigen epitope SIINFEKL in vitro. Taken together, it is con- to cytotoxic T lymphocytes.26) These findings suggest that cluded that LAP can contribute to the trimming process of TAP preferentially transport antigenic peptides as N-ex- antigenic peptide in the cytosol. tended precursor forms into the ER lumen and transported Two other aminopeptidases were also identified as trim- precursors are then trimmed by some ER aminopeptidases. ming enzymes of precursor peptides in the cytosol. It was To elucidate the molecular nature of the trimming pepti- shown that the class I epitope of vesicular stomatistis virus dase in the ER lumen, enzymatic properties of ER aminopep- nucleoprotein (VSV-NP) was first processed through both tidases were characterized. Komlosh et al. showed that the proteasome-dependent and -independent proteolytic steps conversion of ESIINFEKL, a precursor of ovalbumin-derived and subsequently generated by some aminopeptidases.13) antigenic epitope, to SIINFEKL was completely inhibited by AAF-chloromethylketone (CMK) inhibited the cleavage of the metallo-chelator, 1,10-phenanthroline, suggesting that the precursor of VSV-NP epitope with N-terminal flanking 5 metalloenzyme(s) is involved in the antigen processing in the amino acids, SLSDLRGYVYQGL, to the final epitope ER.27) Other aminopeptidase inhibitors such as leucine thiol, RGYVYQGL. In an attempt to purify the enzyme responsi- Leu-CMK and bestatin also reduced the class I antigen pre- ble for SLSDL-AMC

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    4 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us